Amrutanjan Health care has informed that a meeting of the Board of Directors is scheduled to be held on May 16, 2017 to consider and approve Audited Standalone and Consolidated Financials for the Quarter and Year ended March 31, 2017. In view of the above and pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per Company’s Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from May 9, 2017 to May 18, 2017.
The above information is a part of company’s filings submitted to BSE.
